Monte Rosa Therapeutics (NASDAQ:GLUE) Reaches New 52-Week High – Time to Buy? MarketBeat Monte Rosa Therapeutics (NASDAQ:GLUE) Hits New 1-Year High – Here’s Why Nasdaq 100 3 hours
Kezar Life Sciences Stock Scheduled to Reverse Split on Wednesday, October 30th (NASDAQ:KZR) MarketBeat 1 hour
Trade Desk (NASDAQ:TTD) Earns Overweight Rating from Analysts at Wells Fargo & Company MarketBeat 2 hours
AppLovin (NASDAQ:APP) Receives New Coverage from Analysts at Wells Fargo & Company MarketBeat 2 hours
Short Interest in First Trust Mid Cap Value AlphaDEX Fund (NASDAQ:FNK) Expands By 28.2% MarketBeat 2 hours
New Providence Acquisition Corp. II (NASDAQ:NPAB) Short Interest Down 16.7% in October MarketBeat 3 hours
Jeffrey W. Albers Sells 300 Shares of Spyre Therapeutics, Inc. (NASDAQ:SYRE) Stock MarketBeat 3 hours
Tina Marriott Sells 6,000 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Stock MarketBeat 3 hours
Insider Selling: Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Sells 22 Shares of Stock MarketBeat 3 hours
D-Market Elektronik Hizmetler ve Ticaret A.S. (NASDAQ:HEPS) Short Interest Up 92.0% in October MarketBeat 3 hours
D-Market Elektronik Hizmetler ve Ticaret A.S. (NASDAQ:HEPS) Sees Unusually-High Trading Volume – What’s Next? MarketBeat 3 hours